Please login to the form below

Not currently logged in
Email:
Password:

Hansa Medical poaches Vifor Pharma’s CEO

Søren Tulstrup becomes the Swedish biopharma’s CEO and president

Soren TulstropHansa Medical has appointed Søren Tulstrup as its new chief executive officer and president, roles that will see him succeed acting CEO Ulf Wiinberg who reverts to his former role as chairman of the Swedish biopharma.

Tulstrup was most recently CEO of Swiss pharmaceutical group Vifor Pharma and prior to this he served as senior vice president, global franchise head at Shire.

Ulf Wiinberg, chairman at Hansa Medical, said: “Søren is an accomplished life science industry executive, who brings diverse and extensive industry experience having built and led high-performance biopharma companies, country operations and teams both in Europe and the US.”

Additionally, Tulstrup has served as CEO of Santaris Pharma, now part of Roche, and in several senior commercial roles within Merck & Co and Sandoz Pharma.

Wiinberg concluded: “Søren’s strong track record of managing the development, launch and growth of biopharmaceuticals globally for the treatment of rare diseases and kidney diseases greatly matches Hansa Medical’s promising position.”

29th March 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

What are you doing, Dave?
Artificial Intelligence (AI) is invading all areas of healthcare. Is it our saviour or our nemesis?...
Fake News is Bad for your Health
Ill informed patients make poor health decisions...
Secrets of Pharma Advertising
If the goal of branding is to be different, why do so many Pharma brand ads look the same?...

Infographics